SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-140602
Filing Date
2021-04-29
Accepted
2021-04-29 16:36:05
Documents
12
Period of Report
2021-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d181564d8k.htm   iXBRL 8-K 25693
  Complete submission text file 0001193125-21-140602.txt   152826

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA logc-20210426.xsd EX-101.SCH 3070
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20210426_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20210426_pre.xml EX-101.PRE 11860
5 EXTRACTED XBRL INSTANCE DOCUMENT d181564d8k_htm.xml XML 3492
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 21871317
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences